DWA
IRMD icon

Dorsey Wright & Associates’s iRadimed IRMD Stock Holding History

Dorsey Wright & Associates’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,023
Closed -$46K – 295
2022
Q1 		$46K Buy
+1,023
New +$47.3K 0.01% 219
2020
Q4 		– Sell
-310
Closed -$7K – 350
2020
Q3 		$7K Sell
310
-104
-25% -$2.34K ﹤0.01% 269
2020
Q2 		$10K Hold
414
– – ﹤0.01% 247
2020
Q1 		$9K Buy
+414
New +$9.86K ﹤0.01% 160
2019
Q2 		– Sell
-300
Closed -$8K – 310
2019
Q1 		$8K Sell
300
-300
-50% -$7.85K ﹤0.01% 224
2018
Q4 		$15K Buy
+600
New +$16.1K ﹤0.01% 193

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Dorsey Wright & Associates's IRMD Position: Q2 2022 in Review

Dorsey Wright & Associates sold out of iRadimed (IRMD) in Q2 2022, closing a stake of 1,023 shares — an estimated $46K sold.

Dorsey Wright & Associates first reported a position in IRMD in Q4 2018 and held it in 6 quarters. The position peaked at $46K in Q1 2022. 90 funds tracked by Wall St. Rank hold IRMD as of Q2 2022.

  • Dorsey Wright & Associates reported no remaining iRadimed position as of Q2 2022 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,023 iRadimed shares in Q2 2022, an estimated $46K.
  • Dorsey Wright & Associates first reported a position in iRadimed in Q4 2018 and held it in 6 quarters.
  • Dorsey Wright & Associates's iRadimed position peaked at $46K in Q1 2022.
  • 90 funds tracked by Wall St. Rank held iRadimed as of Q2 2022.

Based on Dorsey Wright & Associates's 13F filing for Q2 2022, filed 20 Jul 2022.